The 15,000 doses of Sputnik V, developed by Russia’s Gamaleya Institute, will be used in four cities in the capital region, the Philippines’ coronavirus hotspot, the Department of Health said.
The 15,000 doses of Sputnik V, developed by Russia’s Gamaleya Institute, will be used in four cities in the capital region, the Philippines’ coronavirus hotspot, the Department of Health said.